|  |  | Kelo-cote scar products are marketed and distributed by Advanced Bio-Technologies, Inc. (ABT). ABT is a privately held biopharmaceutical company headquartered in Suwanee, Georgia and is part of the Health Edge Investment Partners portfolio of companies.
We have built a strong portfolio of products that meets the specific needs of medical professionals and their patients. We are experts at understanding the risk factors for abnormal scarring, and have developed unique and highly effective preventative measures that will help create the optimal environment for healing throughout the spectrum of care -- before, during, and after surgery and other procedures.
We are committed to ongoing clinical studies in order to reaffirm the confidence that physicians have in our products. Our scar products are the most widely studied, with more than 2,000 patients participating in clinical trials. It is our dual objective to both manage and help treat abnormal scars and enhance quality of life.
|
|
|
